Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Elvucitabine, a reverse transcriptase inhibitor, is used potentially for the treatment of HBV infection and HIV infection.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,420.00 | |
50 mg | 10-14 weeks | $ 3,180.00 | |
100 mg | 10-14 weeks | $ 4,300.00 |
Description | Elvucitabine, a reverse transcriptase inhibitor, is used potentially for the treatment of HBV infection and HIV infection. |
Synonyms | ACH126443, TY-202, L-D-4FC, beta-L-Fd-4C, ACH 126443, ACH-126443 |
Molecular Weight | 227.19 |
Formula | C9H10FN3O3 |
CAS No. | 181785-84-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Elvucitabine 181785-84-2 β-L-Fd-4C b-L-Fd-4C TY 202 ACH126443 TY-202 TY202 L-D-4FC beta-L-Fd-4C ACH 126443 ACH-126443 inhibitor inhibit